AzTrials
AzTrials

Chronic PainGAINNCT07909473

Group Acupuncture for Pain

A study testing Group Acupuncture Intervention in people with Chronic Pain, run by Duke University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this study is to learn if group acupuncture is acceptable and feasible as a treatment for chronic pain in adults living in rural North Carolina, with the aim of improving access to equitable pain care. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Chronic Pain
What is being tested?
Group Acupuncture Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
103 participants
Where
1 siteUnited States
Study dates
12 Jun 2024to 28 Nov 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adults 18 years and older
  • Experience chronic pain as defined as a response of "most days" or "every day" to the question, "In the past 3 months, how often have you had pain,"
  • Ability to speak/understand English

Who cannot join

  • Self-report of being currently pregnant
  • Show signs of cognitive impairment, including evidence of drug, medication, or alcohol intoxication, that would prevent comprehension of consent and/or is contraindicated when receiving acupuncture (study staff and/or acupuncturists will assess for signs such as orientation to time and place, slurred speech, incoordination, impairment in attention or memory, stupor or drowsiness)
  • Unwillingness to attend acupuncture sessions

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Mebane Historical Museum

    Mebane, North Carolina, 27302

Other trials in United States

About this study

Official title: Group Acupuncture for Improved Pain Relief in Rural Communities

The goal of this study is to learn if group acupuncture is acceptable and feasible as a treatment for chronic pain in adults living in rural North Carolina, with the aim of improving access to equitable pain care.

The main questions it aims to answer are:

Read more

Is group acupuncture acceptable (measured by a questionnaire and semi-structured interviews), feasible (measured by recruitment and retention rates), and delivered with fidelity (measured by the proportion of acupuncture sessions attended) among adults with chronic pain in rural North Carolina (Phase 2)?

Adults with chronic pain will:

  • Attend up to 10 group acupuncture sessions over a 6-week period
  • Complete a questionnaire about the acceptability of the intervention; a subset of participants will complete qualitative acceptability interviews
  • Complete self-report measures of pain, anxiety, depression, sleep, fatigue, and quality of life
Conditions
Chronic Pain
Being tested
Group Acupuncture Intervention
Keywords
chronic pain, acupuncture
Medical subject headings
Chronic Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Group Acupuncture InterventionOther

    Enrolled participants will receive 10 acupuncture treatments over 6 weeks from licensed acupuncturists in a community group setting. Appointments will be staggered every 15-20 minutes, with participants seated comfortably alongside no more than four others. Using a pragmatic approach within North Carolina licensing standards, the acupuncturist will select distal/peripheral points based on assessment and diagnosis. Needling may involve the head, neck, arms, legs, hands, and feet; trunk points will not be used to maintain modesty. Sterile, disposable needles will remain in place for approximately 20-30 minutes. Electroacupuncture will not be used. For each participant and session, the acupuncturist will document the assessment, points needled, needle-retention time, and any adverse effects.

Study groups in NCT07909473
Study groupRoleWhat they receive
Group AcupunctureExperimentalAll participants will receive 10 total acupuncture treatments delivered over 6 weeks by a licensed acupuncturist.
Receives: Other: Group Acupuncture Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Intervention Acceptability

    We assessed acceptability using the Theoretical Framework of Acceptability (TFA) Questionnaire. 7 TFA constructs are assessed, along with general acceptability items scores. Total score max = 35, with higher scores indicating higher acceptability of healthcare intervention.

    Measured: At completion of study (6 weeks)

  2. Feasibility of Enrollment

    we will calculate the proportion of people who were approached for study participation and enrolled

    Measured: Duration of recruitment period, up to approximately 16 months

  3. Feasibility of Data Collection/Retention

    We will calculate the percentage of participants who completed the surveys at each data collection time point (baseline, 3 weeks, 6 weeks) compared to those that did not.

    Measured: From enrollment to completion of study at 6 weeks

  4. Intervention Fidelity

    Reported as the proportion (%) of acupuncture sessions attended (out of 10).

    Measured: Duration of recruitment period, up to approximately 16 months

  5. Intervention Acceptability Qualitative Interviews

    Interviews were conducted on a subset of participants and included questions assessing participant experiences with the intervention, perceived effectiveness of the intervention, and overall acceptability of the intervention. All interviews were transcribed verbatim, and the transcripts served as the data source.

    Measured: At completion of study (6 weeks)

Secondary outcomes (12)
  1. Pain Impact

    PEG Scale Assessing Pain Intensity and Interference (Pain, Enjoyment, General Activity). Score is calculated by adding the scores of its three questions and dividing the total by three to get an average score from 0 to 10.

    Measured: Baseline, 3 weeks, 6 week data collection timepoints

  2. Pain Location

    Pain location (selected on body image); location \& number of pain locations summarized based on participant selection on body map image.

    Measured: Baseline, 3 weeks, 6 weeks

  3. Neuropathic Pain

    PROMIS Neuropathic Pain Quality. T-score generated, with scores ≥ 50 suggesting a likely or prominent neuropathic pain quality phenotype

    Measured: Baseline & 6 weeks data collection timepoints

  4. Nociceptive Pain

    PROMIS Nociceptive Pain questionnaire. T-score generate, with a score >50 suggesting nociceptive pain involvement.

    Measured: Baseline and 6-week data collection timepoint

  5. Pain Self-Efficacy

    Pain Self-Efficacy Questionnaire. Scored by adding the numerical ratings of all 10 items, resulting in a total score from 0 to 60. Higher scores indicate greater pain self-efficacy.

    Measured: Baseline & 6 week data collection timepoint

  6. Pain Concerns

    UW Concerns About Pain 2-item short-form questionnaire. T-score generated, with higher T-score representing higher levels of pain catastrophizing.

    Measured: Baseline & 6-week data collection timepoint

  7. Anxiety

    PROMIS Anxiety Short Form (4-item). Scoring using T-score, with higher scores indicating higher levels of symptoms.

    Measured: Baseline, 3-week, and 6-week data collection timepoint.

  8. Depressive Symptoms

    PROMIS Depressive Symptoms Short Form (4-item). Scoring using T-score, with higher scores indicating higher levels/burden of symptoms.

    Measured: Baseline, 3-week, and 6-week data collection timepoints

  9. Sleep Disturbances

    PROMIS SLeep Disturbances Short-Form (4-item). Scoring using T-score, with higher scores indicating higher severity of sleep disturbance.

    Measured: Baseline, 3-week, and 6-week data collection timepoint

  10. Fatigue

    PROMIS Fatigue Short Form (4-item). Scoring using T-score, with higher scores indicating higher levels/burden of fatigue.

    Measured: Baseline, 3-week, and 6-week data collection timepoint.

  11. Global Physical Health

    PROMIS Global Health - Physical 2-item form. Scoring using T-score, with higher scores indicating better physical health.

    Measured: Baseline, 3-week, & 6-week data collection timepoints.

  12. Current Pain Medication Use

    Assesses if participant is taking medications for pain. If so, questions around the frequency and type of pain medicines an individual is taking.

    Measured: Baseline, 3-week, & 6-week data collection timepoint

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Nov 2026
  2. Study start12 Jun 2024
  3. Primary completion28 Nov 2025
  4. Study completion28 Nov 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
103 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07909473
Sponsor's protocol ID
Pro00114534
Other IDs
GBMF9048
Acronym
GAIN
Status last verified
Oct 2026
First submitted
19 Oct 2026
Last updated
2 Nov 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Group Acupuncture Intervention in people with Chronic Pain, run by Duke University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Intervention Acceptability (time frame: At completion of study (6 weeks)). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in